Searchable abstracts of presentations at key conferences in endocrinology

ea0007oc12 | Development and growth | BES2004

Alterations of the somatotrophic axis in the obese agouti (Ay/a) mouse

Martin N , Houston P , Patterson M , Carmignac D , Ghatei M , Bloom S , Small C

In addition to obesity, models of abnormal hypothalamic melanocortin signalling display increased linear growth, although the mechanism remains unclear. We have studied the somatotrophic axis in the obese agouti (Ay/a) mouse (male, 12-14 weeks), as a model of an altered melanocortin system. Somatotrophic hormones were measured by radioimmunoassay and hypothalamic neuropeptide expression studied by in situhybridisation.Obese A<...

ea0004s21 | Journal of Endocrinology Symposium: Young Innovations - Society for Endocrinology Research Fellows Update | SFE2002

PERINATAL GLUCOCORTICOID TREATMENT, GROWTH AND THE GROWTH HORMONE AXIS

Warne J , Theogaraj E , John C , Houston P , Smith S , Gillies G , Buckingham J

It is well documented that inappropriate exposure to glucocorticoids (GCs) in early life stunts growth and predisposes the individual to metabolic disorders, including type 2 diabetes. Evidence suggests that these programming actions involve alterations in GC receptor expression. However, the precise mechanisms remain to be determined. As GCs are known to modify both the neuroendocrine control of growth hormone (GH) secretion and the peripheral effects of GH on growth and meta...